-transparent.png){kind=logo}
Differentiation of 3T3-L1 preadipocytes into adipocytes is accompanied by increased expression of the nuclear protein C/EBP (CCAAT/enhancer binding protein) and by transcriptional activation of a group of adipose-specific genes. We report here the isolation of the murine C/EBP gene and the characterization of its promoter. Consistent with its proposed role in coordinating transcription during preadipocyte differentiation, an increase in the rate of transcription of the C/EBP gene precedes that of several adipose-specific genes whose promoters are transactivated by C/EBP. DNase I cleavage-inhibition patterns (footprinting) of the C/EBP gene promoter by nuclear factors from differentiated and undifferentiated 3T3-L1 cells identified two sites of differential factor binding. One site in the C/EBP gene promoter between nucleotides -252 and -239 binds a nuclear factor(s) present in preadipocytes that is lost or modified upon differentiation. Another site, between nucleotides -203 and -176, exhibits different but overlapping footprints by nuclear factors present in differentiated and undifferentiated cells. Gel retardation analysis with oligonucleotides corresponding to these sites revealed protein-oligonucleotide complexes containing these differentially expressed nuclear factors. The factor present in differentiated cells that binds at this site was identified as C/EBP (possibly in heterodimeric form with a homologous leucine-zipper protein), suggesting that C/EBP may regulate expression of its own gene.
R J Christy, and
K H Kaestner, and
D E Geiman, and
M D Lane
April 1992,
Genes & development,
R J Christy, and
K H Kaestner, and
D E Geiman, and
M D Lane
September 1989,
Genes & development,
R J Christy, and
K H Kaestner, and
D E Geiman, and
M D Lane
October 2019,
Scientific reports,
R J Christy, and
K H Kaestner, and
D E Geiman, and
M D Lane
September 1994,
Proceedings of the National Academy of Sciences of the United States of America,
R J Christy, and
K H Kaestner, and
D E Geiman, and
M D Lane
June 2020,
Scientific reports,
R J Christy, and
K H Kaestner, and
D E Geiman, and
M D Lane
March 2007,
Biochemical and biophysical research communications,
R J Christy, and
K H Kaestner, and
D E Geiman, and
M D Lane
February 2007,
The FEBS journal,
R J Christy, and
K H Kaestner, and
D E Geiman, and
M D Lane
March 1997,
Obesity research,
R J Christy, and
K H Kaestner, and
D E Geiman, and
M D Lane
July 1999,
Molecular pharmacology,
R J Christy, and
K H Kaestner, and
D E Geiman, and
M D Lane
March 1998,
Biochemical and biophysical research communications,
